Optical Differential Microphone
>
p { margin-top: 0px;margin-bottom: 0px;line-height: 1.15; }
body { font-family: 'Verdana';font-style: Normal;font-weight: normal;font-size: 16px; }
.Normal { telerik-style-type: paragraph;telerik-style-name: Normal;border-collapse: collapse; }
.TableNormal { telerik-style-type: table;telerik-style-name: TableNormal;border-collapse: collapse;...
BP4D: 4D Spontaneous Facial Expression Database
4D Spontaneous Facial Expression Database
Background:
Because posed and un-posed (aka “spontaneous”) 3D facial expressions differ along several dimensions including complexity and timing, well-annotated 3D video of un-posed facial behavior is needed. The BP4D dataset comprises videos of spontaneous facial expressions in a diverse...
Next-Generation Potent and Selective ASCT2 Transport Inhibitors
This technology introduces highly potent and selective small-molecule inhibitors that block glutamine transport through the ASCT2 transporter, a critical metabolic gateway for many aggressive cancers. These compounds overcome the low affinity and poor specificity of existing inhibitors, enabling more effective therapeutic development and precise research...
BP4D+ Multimodal Emotion Dataset for Realistic AI Emotion Recognition
This invention introduces BP4D+, a large scale multimodal spontaneous emotion dataset integrating synchronized 3D facial dynamics, 2D video, thermal imaging, and physiological signals. Designed for real world affective computing, it enables accurate training and benchmarking of AI systems that recognize authentic human emotion.
Background:
Emotion...
Dual-Action Therapy to Prevent L-DOPA-Induced Dyskinesia
This invention repurposes vilazodone, a serotonin reuptake inhibitor and 5-HT1A partial agonist, for dual-action therapy with L-DOPA to reduce Parkinson’s dyskinesia without diminishing motor benefits, offering a more effective long-term treatment strategy.
Background:
L-DOPA is the gold-standard treatment for Parkinson’s disease, but...
Dual-Action Therapy to Prevent L-DOPA-Induced Dyskinesia
This invention repurposes vilazodone, a serotonin reuptake inhibitor and 5-HT1A partial agonist, for dual-action therapy with L-DOPA to reduce Parkinson’s dyskinesia without diminishing motor benefits, offering a more effective long-term treatment strategy.
Background:
L-DOPA is the gold-standard treatment for Parkinson’s disease, but...
FakeCatcher: Detection of Synthetic Portrait Videos using Biological Signals
Novel algorithm uses biological signals to determine the authenticity of videos
Background:
In recent years, technology development of deep learning has advanced to the level of high realism in creating synthetic videos. Such deep fake videos pose a big threat to video authentication for security, safety, privacy protection, as well as health-care...
Multimodal AI Dataset for Emotion and Heart Rate Recognition in Real-World Conditions
This invention introduces the MMSE HR dataset along with a Self Adaptive Matrix Completion algorithm for remote heart rate estimation from facial videos in natural conditions. By combining synchronized spontaneous expression data with physiological signals, it enables accurate, non contact heart rate measurement and real time emotion analysis for robust...